JP2008545703A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545703A5 JP2008545703A5 JP2008513716A JP2008513716A JP2008545703A5 JP 2008545703 A5 JP2008545703 A5 JP 2008545703A5 JP 2008513716 A JP2008513716 A JP 2008513716A JP 2008513716 A JP2008513716 A JP 2008513716A JP 2008545703 A5 JP2008545703 A5 JP 2008545703A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- tissue
- muscle
- medicament
- formulated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 17
- 210000001519 tissue Anatomy 0.000 claims 10
- 210000003205 muscle Anatomy 0.000 claims 6
- 208000028867 ischemia Diseases 0.000 claims 4
- 210000004204 blood vessel Anatomy 0.000 claims 3
- 230000017531 blood circulation Effects 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 206010028289 Muscle atrophy Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000004700 fetal blood Anatomy 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 210000004165 myocardium Anatomy 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002027 skeletal muscle Anatomy 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 210000001988 somatic stem cell Anatomy 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 210000001835 viscera Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68561405P | 2005-05-27 | 2005-05-27 | |
| PCT/US2006/020290 WO2006130433A2 (en) | 2005-05-27 | 2006-05-26 | Treatment of ischemia using stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545703A JP2008545703A (ja) | 2008-12-18 |
| JP2008545703A5 true JP2008545703A5 (enExample) | 2009-12-17 |
Family
ID=37482164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513716A Pending JP2008545703A (ja) | 2005-05-27 | 2006-05-26 | 幹細胞を用いた虚血の処置 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8613906B2 (enExample) |
| EP (2) | EP2662439A1 (enExample) |
| JP (1) | JP2008545703A (enExample) |
| WO (1) | WO2006130433A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070298015A1 (en) * | 2004-04-28 | 2007-12-27 | Viacell, Inc. | Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells |
| GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
| GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| TWI825446B (zh) * | 2020-08-14 | 2023-12-11 | 中國醫藥大學 | 醫藥組合物治療組織缺血狀況之用途 |
| GB2619893A (en) | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
| AU4543193A (en) | 1992-06-22 | 1994-01-24 | Henry E. Young | Scar inhibitory factor and use thereof |
| US6054121A (en) | 1993-02-26 | 2000-04-25 | The Picower Institute For Medical Research | Modulation of immune responses in blood-borne mesenchymal cells |
| US5654186A (en) | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
| US5804446A (en) | 1993-02-26 | 1998-09-08 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
| US5591625A (en) | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5906934A (en) | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
| US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
| US5591444A (en) | 1995-07-28 | 1997-01-07 | Isolagen Technologies, Inc. | Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| DE69634303T2 (de) | 1995-11-16 | 2006-01-05 | Case Western Reserve University, Cleveland | Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen |
| US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US5965436A (en) | 1996-11-15 | 1999-10-12 | Osiris Therapeutics, Inc. | Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes |
| WO1999011287A1 (en) | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
| US7811557B1 (en) | 2000-10-27 | 2010-10-12 | Viacell, Inc. | Methods for improving central nervous system functioning |
| US7560280B2 (en) | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
| EP1708757A4 (en) | 2003-12-19 | 2007-01-17 | Viacell Inc | USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE |
-
2006
- 2006-05-26 EP EP13001977.1A patent/EP2662439A1/en not_active Withdrawn
- 2006-05-26 JP JP2008513716A patent/JP2008545703A/ja active Pending
- 2006-05-26 WO PCT/US2006/020290 patent/WO2006130433A2/en not_active Ceased
- 2006-05-26 EP EP06771203.4A patent/EP1888741B1/en not_active Revoked
- 2006-05-26 US US11/915,660 patent/US8613906B2/en active Active
-
2013
- 2013-11-19 US US14/084,002 patent/US20140079673A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545703A5 (enExample) | ||
| JP2022058688A5 (enExample) | ||
| JP2014530874A5 (enExample) | ||
| JP2018193377A5 (enExample) | ||
| HRP20151230T1 (hr) | Liksisenatid kao dodatak metforminu kod lijeäśenja dijabetesa tipa 2 | |
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2013543899A5 (enExample) | ||
| JP2009513660A5 (enExample) | ||
| AR085662A1 (es) | Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia | |
| JP2010530001A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| CL2008003201A1 (es) | Composicion farmaceutica que comprende 0,5 a 50 mg de gaboxadol o una sal farmaceuticamente aceptable de este, y uno o mas inhibidores de pat1 y/o uno o mas inhibidores de oat, en donde dicha composicion brinda un perfil plasmatico in vivo con un tmax superior a 20 minutos, util en tratamientos de trastornos del sueno. | |
| JP2013541583A5 (enExample) | ||
| WO2007087241A3 (en) | Treatment of ischemic disease using thrombopoietin | |
| JPWO2021099783A5 (enExample) | ||
| JP2018531929A5 (enExample) | ||
| JP2015508765A5 (enExample) | ||
| JP2008545715A5 (enExample) | ||
| JP2018138596A5 (enExample) | ||
| JP2009541409A5 (enExample) | ||
| JP2007119497A5 (enExample) | ||
| JP2012527438A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| JP2009500045A5 (enExample) |